Fundraise / allotmentMajor developmentFiled on BSE ·

Neogen Chemicals Q2 FY2026-27: QIP completed, standalone profit rises to ₹21.14 crore

Neogen Chemicals Ltd · Chemicals & Petrochemicals

What the filing says

  • QIP completed September 16, 2026: 26,60,753 equity shares allotted at ₹2255 per share, gross proceeds ₹600 crore, net proceeds ₹580 crore.
  • Of the QIP net proceeds, ₹230.35 crore was utilised by September 30, 2026, leaving ₹349.65 crore unutilised.
  • Standalone revenue from operations ₹288.00 crore; profit for the period ₹21.14 crore versus ₹9.31 crore in the year-earlier quarter.

Why it's rated major development: the year-on-year change is 127% (50% or more)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Outcome Of Board Meeting

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies Ltd

Electrical Equipment

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals Ltd

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.